CDKN1A and neoplasm: ,29,44, 45, 46 This variation may be explained by the participation of CDKN1A as a master effector in multiple tumor-suppressor pathways that are tightly intertwined, such as cell-cycle arrest, apoptosis, senescence, and DNA repair.24